Acting FDA commissioner pledges to prevent political interference in rare disease meetingnews2026-06-04T17:53:42+00:00June 4th, 2026|Endpoints News|
Dimension seeks up to $750M for third life sciences fund after string of successnews2026-06-04T17:05:08+00:00June 4th, 2026|Endpoints News|
Mammalian hair, roof leaks: Novo Nordisk’s site in Indiana under FDA scrutiny once againnews2026-06-04T16:14:22+00:00June 4th, 2026|Endpoints News|
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug news2026-06-04T15:42:37+00:00June 4th, 2026|Endpoints News|
Lilly, Boehringer retrench in Germany on proposed health spending cutsnews2026-06-04T15:13:21+00:00June 4th, 2026|Endpoints News|
Supreme Court sides with Hikma in ‘skinny label’ casenews2026-06-04T15:04:41+00:00June 4th, 2026|Endpoints News|
